Literature DB >> 25118878

Osteoporosis and the risk of symptomatic nephrolithiasis: a population-based 5-year follow-up study in Taiwan.

Ping-Song Chou1, Chun-Nan Kuo, Kuo-Sheng Hung, Wei-Chiao Chang, Yu-Chien Liao, Ying-Chen Chi, Wei-Po Chou, Shih-Jen Tsai, Mu-En Liu, Chiou-Lian Lai, Yii-Her Chou, Wei-Pin Chang.   

Abstract

This study estimates the risk of symptomatic nephrolithiasis within 5 years of newly diagnosed osteoporosis in a Taiwan population. This cohort study consisted of patients with a diagnosis of osteoporosis between Jan. 2003 and Dec. 2005 (N = 1634). Four age- and gender- matched patients for every patient in the study cohort were selected using random sampling as the comparison cohort (N = 6536). All patients were tracked for 5 years from the date of cohort entry to identify whether they developed symptomatic nephrolithiasis. Cox proportional hazard regressions were performed to evaluate the 5-year nephrolithiasis-free survival rates. During the 5-year follow-up period, 60 osteoporosis patients (3.7%) and 165 non- osteoporosis patients (2.5%) developed symptomatic nephrolithiasis. The adjusted HR of symptomatic nephrolithiasis was 1.38 times greater risk for patients with osteoporosis than for the comparison cohort (95% confidence interval (CI) 1.03-1.86; P < .05). Osteoporosis is very likely to be an independent risk factor for subsequent diagnosis of symptomatic nephrolithiasis.

Entities:  

Mesh:

Year:  2014        PMID: 25118878     DOI: 10.1007/s00223-014-9895-y

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  6 in total

1.  Stones: Bone health in patients with kidney stones.

Authors:  Miguel Angel Arrabal-Polo; Miguel Arrabal-Martin
Journal:  Nat Rev Urol       Date:  2014-12-09       Impact factor: 14.432

2.  The importance of urinary calcium in postmenopausal women with osteoporotic fracture.

Authors:  Miguel Angel Ochoa-Hortal Rull; María Del Carmen Cano-García; Miguel Arrabal-Martín; Miguel Angel Arrabal-Polo
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

3.  Use of whole-exome sequencing to identify a novel ADCY10 mutation in a patient with nephrolithiasis.

Authors:  Chenyu Wang; Ran Du; Jieyuan Jin; Yi Dong; Jishi Liu; Liangling Fan; Rong Xiang
Journal:  Am J Transl Res       Date:  2020-08-15       Impact factor: 4.060

4.  Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.

Authors:  María Sierra Girón-Prieto; Salvador Arias-Santiago; María Del Carmen Cano-García; Antonio Poyatos-Andújar; Tomás de Haro-Muñoz; Felix Abad-Menor; Miguel Quesada-Charneco; Miguel Ángel Arrabal-Polo; Miguel Arrabal-Martín
Journal:  Int Urol Nephrol       Date:  2016-07-04       Impact factor: 2.370

Review 5.  Idiopathic Osteoporosis and Nephrolithiasis: Two Sides of the Same Coin?

Authors:  Domenico Rendina; Gianpaolo De Filippo; Gabriella Iannuzzo; Veronica Abate; Pasquale Strazzullo; Alberto Falchetti
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

6.  The Risk of Nephrolithiasis Among Patients With Ankylosing Spondylitis: a Population-Based Cohort Study.

Authors:  Mu Tsun Shih; Shou Hung Tang; Tai Lung Cha; Sheng Tang Wu; Jen Huai Chiang; Wen Chi Chen
Journal:  Arch Rheumatol       Date:  2016-08-01       Impact factor: 1.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.